e-learning
resources
Amsterdam 2015
Sunday, 27.09.2015
Occupational disease: clinical cases and series
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
A new chemical causing IgE-mediated sensitization and asthma
Hille Suojalehto (Helsinki, Finland), Hille Suojalehto, Kirsi Karvala, Katriina Ylinen, Irmeli Lindströn
Source:
International Congress 2015 – Occupational disease: clinical cases and series
Session:
Occupational disease: clinical cases and series
Session type:
Thematic Poster Session
Number:
1146
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Hille Suojalehto (Helsinki, Finland), Hille Suojalehto, Kirsi Karvala, Katriina Ylinen, Irmeli Lindströn. A new chemical causing IgE-mediated sensitization and asthma. Eur Respir J 2015; 46: Suppl. 59, 1146
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Late Breaking Abstract - Efficacy of Breathox® device inhalation on acute symptoms associated with COVID-19 (BREATH study)
Related content which might interest you:
Risk factors of incomplete asthma control in asthmatic patients with allergic rhinitis
Source: Annual Congress 2013 –Asthma
Year: 2013
Comorbidity of allergic rhinitis and asthma to birch allergen in an environmental exposure chamber
Source: International Congress 2015 – Immune aspects of asthma and other airway diseases
Year: 2015
A phenotype of onset of adult asthma with co-morbid rhinitis
Source: Annual Congress 2013 –Asthma
Year: 2013
Allergic versus non allergic asthma: What makes the difference?
Source: International Congress 2015 – Clincal aspects of asthma: monitoring and mechanisms
Year: 2015
Clinical characteristics of seasonal rhinitis and co-existence with asthma
Source: International Congress 2016 – Clinical studies in asthma and immunology
Year: 2016
Sensitization to three mites in Cuban children with allergic respiratory diseases
Source: International Congress 2014 – Paediatric asthma: epidemiology and risk factors
Year: 2014
Allergic rhinitis does it have an impact on controller asthma therapy choice
Source: International Congress 2014 – Paediatric asthma: pharmacological and non-pharmacological management
Year: 2014
Relationship between specific rhinitis symptom and control status of asthma
Source: International Congress 2015 – Clincal aspects of asthma: monitoring and mechanisms
Year: 2015
Allergen analysis of 2778 patients with allergic diseases in China
Source: International Congress 2016 – Laboratory tests and cell biology in allergy and immunology
Year: 2016
Occupational asthma as a result of severe asthma
Source: International Congress 2015 – Occupational disease: clinical cases and series
Year: 2015
Determinants of non-adherence to pharmacologic allergic rhinitis treatment
Source: Annual Congress 2013 –Treatment and management of asthma in primary care
Year: 2013
Occupational asthma due to cleaning agents
Source: Annual Congress 2013 –Occupational respiratory diseases: asthma, silicosis and asbestosis
Year: 2013
25(OH) vitamin D levels in pediatric asthma and allergic rhinitis
Source: International Congress 2014 – More paediatric asthma
Year: 2014
Chronic rhinosinusitis and the prevalence of asthma
Source: Annual Congress 2013 –Genetics and mechanisms of, and tests for, allergy
Year: 2013
Patients with allergic and eosinophilic asthma in the German severe asthma registry
Source: International Congress 2015 – Asthma and lung immunology
Year: 2015
Predictors factors for asthma in patients with rhinitis
Source: International Congress 2014 – Clinical allergy
Year: 2014
Allergic and non-allergic childhood asthma is characterized by novel biomarkers and signaling pathways
Source: International Congress 2014 – Paediatric asthma: markers and molecules
Year: 2014
Pharmacogenetics in severity of bronchial hyperresponsiveness in asthma
Source: Annual Congress 2013 –Genetic factors in airway development and disease
Year: 2013
Sensitization to moulds in patients with newly diagnosed allergic asthma
Source: International Congress 2015 – Immune aspects of asthma and other airway diseases
Year: 2015
Asthma phenotypes in children: Allergic versus non allergic
Source: International Congress 2016 – Living with asthma around the globe
Year: 2016
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept